Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000481

Drug Information
SynonymsAstraZeneca Brand of Seloken; Dutoprol; Meijoprolol; 1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol; Tartrate, Metoprolol; L000669; AstraZeneca Brand of Metaoprolol Tartrate; LOPRESSIDONE; Metoprololum; Spesikor; Preblok; Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate; I06-0125; H 93 26; H 9326; 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol; Jsp006606; Lopressor; CGP 2175; (RS)-Metoprolol; 37350-58-6; EINECS 253-483-7; NCGC00021148-03; 1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol; MolPort-005-938-039; 2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, (.+/-.)-; 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol; Toprol; Betalok; Selo-Zok; 1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol; BRD-A03623303-045-02-0; Betaloc; Betaloc-Astra; Lopresoretic; NCGC00021148-04; Seloken AstraZeneca Brand; Metohexal; CHEMBL13; Beloc-Duriles; Beatrolol; Metoprololum [INN-Latin]; Metoprolol succinate; Beloc Duriles; D008790; AB00053499; dl-Metoprolol; 2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-; AC1L1HKM; Presolol; LS-122450; AC-19022; CGP-2175; BetalocAstra; D02358; HSDB 6531; H 93-26; CHEBI:6904; I01-7125; CID4171; BelocDuriles; C07202; 2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-; Betaloc Astra; EINECS 257-166-4; 51384-51-1; CGP2175; Novartis Brand of Metprolol Tartrate; 54163-88-1; UNII-GEB06NHM23; Metoprolol (USAN/INN); Spesicor; HMS2090B15; Seroken; Seloken; TOPROL-XL; CCRIS 4198; Metoprolol [USAN:INN:BAN]; Lopresor; Metroprolol; 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; 3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol; NCGC00021148-02; DB00264; metoprolol
Trade NameLopressor; Toprol-XL; Selokeen; Minax; Metrol; Betaloc; Neobloc; Corvitol
[ICD9: 401   ICD10: I10, I11, I12, I13, I15]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntihypertensive Agents
CAS NumberCAS 37350-58-6
PubChem Compound IDCID 4171.
PubChem Substance IDSID 9411.
SuperDrug ATC IDC07AB02
SuperDrug CAS ID037350586;
TargetBeta-1 adrenergic receptorAntagonist[2][3][4]
Ref 1The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs. Mol Pharm. 2004 Sep-Oct;1(5):357-62. To Reference
Ref 2Prediction and experimental validation of acute toxicity of beta-blockers in Ceriodaphnia dubia. Environ Toxicol Chem. 2005 Oct;24(10):2470-6. To Reference
Ref 3Nat Rev Drug Discov. 2003 Jan;2(1):38-51.Knockouts model the 100 best-selling drugs--will they model the next 100? To Reference
Ref 4Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists. Eur J Clin Pharmacol. 1998 Feb;53(6):389-404. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543